论文信息 - Anticoagulant counter ion impact on bioanalytical LC-MS/MS assay performance: additional validation required? - 字舞流文

Anticoagulant counter ion impact on bioanalytical LC-MS/MS assay performance: additional validation required?

Magnus Knutsson | Philip Timmerman | Peter van Amsterdam | M. Knutsson | P. Timmerman | Carl Johan Sennbro | C. Sennbro | P. van Amsterdam

[1] Liliana Rivera-Espinosa,et al. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. , 2009, Clinical therapeutics.

[2] Magnus Knutsson,et al. Conference Report: From challenges to solutions , 2011 .

[3] Vinod P. Shah,et al. Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays , 2007 .

[4] Magnus Knutsson,et al. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum. , 2011, Bioanalysis.

[5] Fabio Garofolo,et al. The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis. , 2009, Bioanalysis.

[6] Fabio Garofolo,et al. Impact of plasma and whole-blood anticoagulant counter ion choice on drug stability and matrix effects during bioanalysis. , 2009, Bioanalysis.